Skip to content
Study details
Enrolling now

BE WELL With Migraine: Brain Education and WELLness With Migraine

Wake Forest University Health Sciences
NCT IDNCT05987592ClinicalTrials.gov data as of Apr 2026
Target enrollment

286

Study length

about 2.9 years

Ages

18+

Locations

3 sites in MA, NC, OH

What this study is about

This trial is testing two different non-drug, virtual treatment options designed to improve the lives of patients with migraine. Both interventions involve 8 weekly sessions and an online platform with additional content and learning. Participants can stay on all their medications during it.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Participate in Brain Education and WELLness with Migraine Group A
  • 2.Participate in Brain Education and WELLness with Migraine Group B

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Secondary: Anxiety assessed using Generalized Anxiety Disorder-7 (GAD-7) at 8 weeks - Change in anxiety from baseline to 8 weeks, Depression assessed using Patient Health Questionnaire (PHQ-8) Questionnaire - Change in Depression from baseline to 8 weeks, Pain Catastrophizing quantified using Pain Catastrophizing Scale (PCS) - Change in Pain catastrophizing from baseline to 8 weeks, Quality of Life assessed using Migraine Specific Quality of Life version 2.1 (MSQL v2.1) at 8 weeks, Self-Efficacy assessed with the Headache Management Self-Efficacy Scale (HMSE) - Change in Self-efficacy from baseline to 8 weeks

Body systems

Neurology